Drug Profile
NNY-RANTES
Alternative Names: N-nonanoyl-RANTESLatest Information Update: 23 Apr 2002
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class
- Mechanism of Action CCR5 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported HIV infections
Most Recent Events
- 14 Aug 2000 New profile
- 14 Aug 2000 Preclinical development for HIV infections treatment in France (Unknown route)